Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D. (Q45408096)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 December 2006

Language	Label	Description	Also known as
English	Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D.	scientific article published on 12 December 2006

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D. (English)

1 reference

Europe PubMed Central

14 December 2017

equine encephalitis

1 reference

based on heuristic

inferred from title

Venezuelan equine encephalitis

1 reference

based on heuristic

inferred from title

author name string

Jacek Kowalski

1

1 reference

Europe PubMed Central

14 December 2017

Karissa Adkins

2

1 reference

Europe PubMed Central

14 December 2017

Seema Gangolli

3

1 reference

Europe PubMed Central

14 December 2017

Jian Ren

4

1 reference

Europe PubMed Central

14 December 2017

Heather Arendt

5

1 reference

Europe PubMed Central

14 December 2017

Joanne DeStefano

6

1 reference

Europe PubMed Central

14 December 2017

Jennifer Obregon

7

1 reference

Europe PubMed Central

14 December 2017

Donna Tummolo

8

1 reference

Europe PubMed Central

14 December 2017

Robert J Natuk

9

1 reference

Europe PubMed Central

14 December 2017

Tom P Brown

10

1 reference

Europe PubMed Central

14 December 2017

Christopher L Parks

11

1 reference

Europe PubMed Central

14 December 2017

Stephen A Udem

12

1 reference

Europe PubMed Central

14 December 2017

Deborah Long

13

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

12 December 2006

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

25

1 reference

Europe PubMed Central

14 December 2017

12

1 reference

Europe PubMed Central

14 December 2017

2296-2305

1 reference

Europe PubMed Central

14 December 2017

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Venezuelan equine encephalitis replicon immunization overcomes intrinsic tolerance and elicits effective anti-tumor immunity to the 'self' tumor-associated antigen, neu in a rat mammary tumor model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Replicase complex genes of Semliki Forest virus confer lethal neurovirulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Deletions in the hypervariable domain of the nsP3 gene attenuate Semliki Forest virus virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

A method of alphavirus replicon particle titration based on expression of functional replicase/transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Mouse Encephalitis Induced by Avirulent Semliki Forest Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Identification of genes involved in the host response to neurovirulent alphavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Viruses selectively upregulate Toll-like receptors in the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

based on heuristic

inferred from DOI database lookup

The transmembrane domains of Sindbis virus envelope glycoproteins induce cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.063

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.11.063

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45408096&oldid=1527202696"